These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Retinal and ciliary body pigment epithelium suppress activation of T lymphocytes via transforming growth factor beta. Sugita S; Futagami Y; Smith SB; Naggar H; Mochizuki M Exp Eye Res; 2006 Dec; 83(6):1459-71. PubMed ID: 16996057 [TBL] [Abstract][Full Text] [Related]
4. CTLA-4+CD8+ T cells that encounter B7-2+ iris pigment epithelial cells express their own B7-2 to achieve global suppression of T cell activation. Sugita S; Ng TF; Schwartzkopff J; Streilein JW J Immunol; 2004 Apr; 172(7):4184-94. PubMed ID: 15034031 [TBL] [Abstract][Full Text] [Related]
5. B7+ iris pigment epithelium induce CD8+ T regulatory cells; both suppress CTLA-4+ T cells. Sugita S; Ng TF; Lucas PJ; Gress RE; Streilein JW J Immunol; 2006 Jan; 176(1):118-27. PubMed ID: 16365402 [TBL] [Abstract][Full Text] [Related]
6. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-beta-producing regulatory T cells. Yoshida M; Kezuka T; Streilein JW Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3862-70. PubMed ID: 11053287 [TBL] [Abstract][Full Text] [Related]
8. Thrombospondin-1-dependent immune regulation by transforming growth factor-β2-exposed antigen-presenting cells. Mir FA; Contreras-Ruiz L; Masli S Immunology; 2015 Dec; 146(4):547-56. PubMed ID: 26458493 [TBL] [Abstract][Full Text] [Related]
9. Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms. Ishida K; Panjwani N; Cao Z; Streilein JW Ocul Immunol Inflamm; 2003 Jun; 11(2):91-105. PubMed ID: 14533028 [TBL] [Abstract][Full Text] [Related]
10. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells. Sugita S; Keino H; Futagami Y; Takase H; Mochizuki M; Stein-Streilein J; Streilein JW Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5376-84. PubMed ID: 17122127 [TBL] [Abstract][Full Text] [Related]
11. Human retinal pigment epithelium-induced CD4+CD25+ regulatory T cells suppress activation of intraocular effector T cells. Horie S; Sugita S; Futagami Y; Yamada Y; Mochizuki M Clin Immunol; 2010 Jul; 136(1):83-95. PubMed ID: 20350837 [TBL] [Abstract][Full Text] [Related]
12. Suppression of bystander T helper 1 cells by iris pigment epithelium-inducing regulatory T cells via negative costimulatory signals. Sugita S; Horie S; Yamada Y; Keino H; Usui Y; Takeuchi M; Mochizuki M Invest Ophthalmol Vis Sci; 2010 May; 51(5):2529-36. PubMed ID: 19959639 [TBL] [Abstract][Full Text] [Related]
13. Human iris pigment epithelium suppresses activation of bystander T cells via TGFbeta-TGFbeta receptor interaction. Horie S; Sugita S; Futagami Y; Kawaguchi T; Kamoi K; Shirato S; Mochizuki M Exp Eye Res; 2009 Jun; 88(6):1033-42. PubMed ID: 19450450 [TBL] [Abstract][Full Text] [Related]
14. Immunological homeostasis of the eye. Mochizuki M; Sugita S; Kamoi K Prog Retin Eye Res; 2013 Mar; 33():10-27. PubMed ID: 23108335 [TBL] [Abstract][Full Text] [Related]
15. Role of ocular pigment epithelial cells in immune privilege. Sugita S Arch Immunol Ther Exp (Warsz); 2009; 57(4):263-8. PubMed ID: 19568919 [TBL] [Abstract][Full Text] [Related]
16. Thrombospondin plays a vital role in the immune privilege of the eye. Zamiri P; Masli S; Kitaichi N; Taylor AW; Streilein JW Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):908-19. PubMed ID: 15728547 [TBL] [Abstract][Full Text] [Related]
17. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact. Yoshida M; Takeuchi M; Streilein JW Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):811-21. PubMed ID: 10711698 [TBL] [Abstract][Full Text] [Related]
18. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. Sugita S; Streilein JW J Exp Med; 2003 Jul; 198(1):161-71. PubMed ID: 12835481 [TBL] [Abstract][Full Text] [Related]